Insufficient scRNA-seq data for expression of IL25 at single-cell level.
Insufficient scRNA-seq data for expression of IL25 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
heart | 87% | 16.93 | 746 / 861 | 0% | 0 | 0 / 0 |
prostate | 84% | 7.49 | 205 / 245 | 0% | 0 | 0 / 502 |
muscle | 78% | 9.06 | 627 / 803 | 0% | 0 | 0 / 0 |
breast | 75% | 5.06 | 346 / 459 | 0% | 0.01 | 5 / 1118 |
brain | 72% | 4.03 | 1894 / 2642 | 0% | 0.01 | 3 / 705 |
thymus | 69% | 3.36 | 453 / 653 | 2% | 0.05 | 14 / 605 |
adipose | 71% | 4.36 | 854 / 1204 | 0% | 0 | 0 / 0 |
ovary | 67% | 2.89 | 120 / 180 | 0% | 0.00 | 1 / 430 |
uterus | 66% | 3.58 | 112 / 170 | 0% | 0.00 | 1 / 459 |
blood vessel | 62% | 2.78 | 823 / 1335 | 0% | 0 | 0 / 0 |
skin | 60% | 7.32 | 1088 / 1809 | 0% | 0 | 0 / 472 |
spleen | 54% | 3.12 | 130 / 241 | 0% | 0 | 0 / 0 |
bladder | 52% | 2.29 | 11 / 21 | 0% | 0.47 | 1 / 504 |
lung | 51% | 2.05 | 297 / 578 | 0% | 0.01 | 5 / 1155 |
esophagus | 45% | 1.61 | 653 / 1445 | 0% | 0 | 0 / 183 |
kidney | 43% | 1.43 | 38 / 89 | 0% | 0.00 | 1 / 901 |
stomach | 42% | 1.38 | 152 / 359 | 0% | 0 | 0 / 286 |
intestine | 38% | 1.29 | 363 / 966 | 0% | 0 | 0 / 527 |
adrenal gland | 24% | 0.70 | 61 / 258 | 0% | 0 | 0 / 230 |
pancreas | 10% | 0.27 | 34 / 328 | 0% | 0 | 0 / 178 |
peripheral blood | 8% | 0.19 | 70 / 929 | 0% | 0 | 0 / 0 |
liver | 6% | 0.16 | 14 / 226 | 0% | 0.01 | 1 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0009624 | Biological process | response to nematode |
GO_0009620 | Biological process | response to fungus |
GO_0030222 | Biological process | eosinophil differentiation |
GO_0008150 | Biological process | biological_process |
GO_0002437 | Biological process | inflammatory response to antigenic stimulus |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0030380 | Molecular function | interleukin-17E receptor binding |
GO_0005125 | Molecular function | cytokine activity |
Gene name | IL25 |
Protein name | Interleukin-25 (IL-25) (Interleukin-17E) (IL-17E) |
Synonyms | IL17E UNQ3120/PRO10272 |
Description | FUNCTION: Cytokine produced by various cells such as eosinophils, T-helper type 2 (Th2) cells or epithelial cells that plays a role in internal safety of adaptive immune responses by regulating cytokine production . Promotes and augments T-helper type 2 responses locally or systemically . Exerts its activity via its receptor composed of IL17RA and IL17RB for signal transduction (By similarity). In turn, stimulates the JAK2-STAT5A pathway and promotes the secretion of type-2 associated cytokines including IL4, IL9 and IL13 . Induces also the release of IL8, and IL6 from eosinophils through the combined activation of MAPK and NF-kappa-B pathways . Inhibits the differentiation of T-helper (Th17) cells via the production of IL4, IL5 and IL13 . . |
Accessions | ENST00000397242.3 [Q9H293-2] ENST00000329715.2 [Q9H293-1] Q9H293 |